Application 207588
- Type
- ANDA
- Sponsor
- WATSON LABS TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207588-001 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-002 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-003 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-004 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-005 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-006 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-007 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-008 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-009 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-010 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-011 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | |
| A207588-012 | LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207588-001 | AB1 |
| A207588-001 | AB2 |
| A207588-001 | AB3 |
| A207588-001 | AB4 |
| A207588-002 | AB1 |
| A207588-002 | AB2 |
| A207588-002 | AB3 |
| A207588-002 | AB4 |
| A207588-003 | AB1 |
| A207588-003 | AB2 |
| A207588-003 | AB3 |
| A207588-003 | AB4 |
| A207588-004 | AB1 |
| A207588-004 | AB2 |
| A207588-004 | AB3 |
| A207588-004 | AB4 |
| A207588-005 | AB1 |
| A207588-005 | AB2 |
| A207588-005 | AB3 |
| A207588-005 | AB4 |
| A207588-006 | AB1 |
| A207588-006 | AB2 |
| A207588-006 | AB3 |
| A207588-006 | AB4 |
| A207588-007 | AB1 |
| A207588-007 | AB2 |
| A207588-007 | AB3 |
| A207588-007 | AB4 |
| A207588-008 | AB1 |
| A207588-008 | AB2 |
| A207588-008 | AB3 |
| A207588-008 | AB4 |
| A207588-009 | AB1 |
| A207588-009 | AB2 |
| A207588-009 | AB3 |
| A207588-009 | AB4 |
| A207588-010 | AB1 |
| A207588-010 | AB2 |
| A207588-010 | AB3 |
| A207588-010 | AB4 |
| A207588-011 | AB1 |
| A207588-011 | AB2 |
| A207588-011 | AB3 |
| A207588-011 | AB4 |
| A207588-012 | AB1 |
| A207588-012 | AB2 |
| A207588-012 | AB3 |
| A207588-012 | AB4 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-005 | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-006 | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-007 | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-008 | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-009 | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-010 | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-011 | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207588-012 | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-001 | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-002 | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-003 | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207588-004 | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3,AB4 | 2022-05-10 | fd3edfee7708… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-001 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-002 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-003 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-004 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-005 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-006 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-007 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-008 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-009 | AB4 | 4 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB2 | 2 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB3 | 3 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207588-010 | AB4 | 4 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 64aaeba7-1013-44a4-96fc-b876016897b3 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 65b266af-72a5-4409-ab55-bd14341135aa | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 702016f6-8507-471f-b833-3a582aef5d2e | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | a55e735f-a5b0-4b85-9fd7-3a4b6723a81b | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | e1f77539-2156-4890-baca-8b13779c745c | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | b4f8dfd0-b15a-4da5-a0d0-ad768e0b7ff8 | 2024-09-01 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Teva Pharmaceuticals, Inc. | 60cadfd7-82b5-4207-97e1-1dd0655efb27 | 2024-06-01 | Boxed warning, Warnings, Adverse reactions | 207588 ANDA207588 0480-8715 0480-8704 0480-8687 0480-8710 0480-8693 0480-8707 0480-8718 0480-8722 0480-8690 0480-8725 0480-8682 0480-8701 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0480-8682 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8682 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8682 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8687 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8687 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8687 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8690 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8690 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8690 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8693 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8693 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8693 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8701 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8701 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8701 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8704 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8704 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8704 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8707 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8707 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8707 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8710 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8710 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8710 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8715 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8715 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8715 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8718 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8718 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8718 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8722 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8722 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8722 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8725 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8725 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |
| 0480-8725 | Levothyroxine sodium | Levothyroxine sodium | Teva Pharmaceuticals, Inc. | ANDA | Current |